A Bay Area biotech company saw its obesity drug fail in clinical trials just five months ago. Now it's being acquired for nearly $7 billion after shifting its focus to a different disease.

After taking a gamble in seeking a new mandate, Thailand's newly reelected PM Anutin Charnvirakul has cast himself as a force ...

Dayton education nominees will be judged on: career history and significant achievements; community involvement and ...

Staff at the Australian Broadcasting Corporation will strike for the first time in 20 years.

Since 2020, Russia has been expanding its presence in the Sahel region, seizing the initiative from Paris and Washington and enhancing its standing across sub-Saharan Africa. Recognizing that mounting ...

It comes amid concern over the rising cost of oil and gas, following the outbreak of the US-Israel war with Iran.

Thoughts on investing in Olympia Financial Group, U.S. market risks, returning to DIY investing as a millionaire, and more ...

MP Bradley Thomas has urged residents to use the towns Post Office counter in TG Jones on Bromsgrove High Street after it was ...

New York City officials still have not fully explained how payroll cards from a summer jobs program were used to withdraw ...

The ultra-rich principality of Monaco may seem like an odd choice for Pope Leo XIV's first official European overseas trip on ...

Threat actors abused trusted Trivy distribution channels to inject credential‑stealing malware into CI/CD pipelines worldwide ...

Scientists are tracing back the history of dogs using the oldest genes from the species ever studied. Scientists think dogs ...